FM
Frazier Management Portfolio holdings
AUM
$1.12M
This Quarter Return
-29.82%
1 Year Return
+150.24%
3 Year Return
+430.4%
5 Year Return
+1,926.83%
10 Year Return
–
AUM
$162M
AUM Growth
+$162M
(-32%)
Cap. Flow
+$182K
Cap. Flow
% of AUM
0.11%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
Collegium Pharmaceutical
COLL
|
$182K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Glaukos
GKOS
$5.5B
| $43.9M | 27.02% | 2,603,362 | – | – |
|
|
2
Collegium Pharmaceutical
COLL
$1.22B
| $34.3M | 21.08% | 1,887,332 +10,000 | +0.5% | +$182K |
|
3
Amicus Therapeutics
FOLD
$2.34B
| $24.7M | 15.18% | 2,918,291 | – | – |
|
|
TBRA
4
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
| $21.8M | 13.44% | 2,668,570 | – | – |
|
5
Cidara Therapeutics
CDTX
$1.66B
| $16.7M | 10.26% | 1,312,258 | – | – |
|
|
SRRA
6
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $14.7M | 9.07% | 2,186,195 | – | – |
|
|
RXDX
7
DELISTED
Ignyta, Inc.
RXDX
| $6.43M | 3.96% | 950,366 | – | – |
|